CSP #512 - Options in Management With Anti-Retrovirals (OPTIMA)

This study has been completed.

Sponsor:

Collaborators:

Medical Research Council

Canadian Institutes of Health Research (CIHR)

Information provided by:

Department of Veterans Affairs

ClinicalTrials.gov Identifier:

NCT00050089

First received: November 20, 2002

Last updated: October 24, 2008

Last verified: October 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	December 2007
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)

No publications provided by Department of Veterans Affairs

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Holodniy M, Brown ST, Cameron DW, Kyriakides TC, Angus B, Babiker A, Singer J, Owens DK, Anis A, Goodall R, Hudson F, Piaseczny M, Russo J, Schechter M, Deyton L, Darbyshire J; OPTIMA Team. Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial. PLoS One. 2011 Mar 31;6(3):e14764.

Joyce VR, Barnett PG, Chow A, Bayoumi AM, Griffin SC, Sun H, Holodniy M, Brown ST, Kyriakides TC, Cameron DW, Youle M, Sculpher M, Anis AH, Owens DK. Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trial. Med Decis Making. 2012 Jan-Feb;32(1):70-82. Epub 2011 Mar 7.

To Top